Delivery Order SPE2DB24D1201-SPE2DB24FJALP

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,082.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a pharmaceutical product. The contract has a period of performance ending on May 27, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a $22,159.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the provision of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract has a potential value of $1,801.86 and a completion date of February 23, 2024. This delivery order is issued under a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a medication, and has a firm fixed price of $1,450.92 with a completion date of May 20, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $17,724.35, and a period of performance through June 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of REPATHA 140 MG/ML SURECLICK medication. The $15,095.01 award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary contract vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,162.72, is for the supply of REPATHA 140 MG/ML SURECLICK ML, a specialty medication. The contract is a firm fixed-price type with an ultimate completion date of June 24, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.35, is for the provision of REPATHA 140 MG/ML SURECLICKML, a cardiovascular medication. The contract is a firm fixed-price delivery order with a period of performance extending to March 13, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a prescription medication, at a firm fixed price of $2,152.06. The contract has an ultimate completion date of May 15, 2025 and was awarded on May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a $3,159.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK syringes and has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJALP
    Delivery Order

This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the provision of REPATHA 140 MG/ML SURECLICKML, a prescription medication. The order has a firm fixed price of $1,387.80 and an ultimate completion date of July 10, 2024. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. There is no set-aside designation for this specific award.

Generated 10/8/24, 9:11 AM